Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jingbo Hu, Min Wang & Yufen Zhao. (2018) SAR342434 - an insulin biosimilar for the treatment of type II diabetes. Expert Opinion on Biological Therapy 18:11, pages 1107-1112.
Read now
Read now
Jingbo Hu, Aiping Deng & Yufen Zhao. (2018) Ertugliflozin as a monotherapy for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 19:16, pages 1841-1847.
Read now
Read now
Xia Zhou, Kejing Wu, Ruimin Long, Ranjith Kumar Kankala, Shibin Wang & Yuangang Liu. (2018) Preparation of a MVL-Ca-Alg/CS MEMs system with add-on effect for type 2 diabetes treatment. International Journal of Polymeric Materials and Polymeric Biomaterials 67:14, pages 823-829.
Read now
Read now
André J. Scheen. (2017) Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes. Expert Review of Clinical Pharmacology 10:12, pages 1303-1316.
Read now
Read now
Xueying Tan, Xiaojing Cao, Minzhi Zhou, Ping Zou & Jingbo Hu. (2017) Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes. Expert Opinion on Investigational Drugs 26:9, pages 1083-1089.
Read now
Read now
Articles from other publishers (14)
Xiaoying Zhao, Rui Ning, Andrew Hui, David W. Boulton & Weifeng Tang. (2023) Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-Release Fixed-Dose Combination in Healthy Chinese Volunteers and Regional Comparison. Clinical Therapeutics.
Crossref
Crossref
Kosar Malekpour, Ali Hazrati, Sara Soudi, Leila Roshangar, Ali Akbar Pourfathollah & Majid Ahmadi. (2023) Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells. Heliyon 9:5, pages e15489.
Crossref
Crossref
Kumar Gautam, Ratikanta Tripathy, Dayanidhi Meher & Jyoti Prakash Sahoo. (2023) Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study. Cureus.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
199
229
.
Sónia Romano, Heloísa Galante, Débora Figueira, Zilda Mendes & António Teixeira Rodrigues. (2021) Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Research in Social and Administrative Pharmacy 17:1, pages 1876-1881.
Crossref
Crossref
Dong-Gyun Han, Hwayoung Yun & In-Soo Yoon. (2019) A novel high-performance liquid chromatographic method combined with fluorescence detection for determination of ertugliflozin in rat plasma: Assessment of pharmacokinetic drug interaction potential of ertugliflozin with mefenamic acid and ketoconazole. Journal of Chromatography B 1122-1123, pages 49-57.
Crossref
Crossref
Weifeng Tang, Helena Engman, Yali Zhu, Brian Dayton & David W. Boulton. (2019) Bioequivalence and Food Effect of Dapagliflozin/Saxagliptin/Metformin Extended-release Fixed-combination Drug Products Compared With Coadministration of the Individual Components in Healthy Subjects. Clinical Therapeutics 41:8, pages 1545-1563.
Crossref
Crossref
Caroline Daems, Sophie Welsch, Hasnae Boughaleb, Juliette Vanderroost, Annie Robert, Etienne Sokal & Philippe A. Lysy. (2019)
Early Treatment with Empagliflozin and GABA Improves
β
-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
. Journal of Diabetes Research 2019, pages 1-14.
Crossref
Crossref
Mahnaz Bahri Khomami, Anju E. Joham, Jacqueline A. Boyle, Terhi Piltonen, Michael Silagy, Chavy Arora, Marie L. Misso, Helena J. Teede & Lisa J. Moran. (2019) Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—A systematic review, meta‐analysis, and meta‐regression. Obesity Reviews 20:5, pages 659-674.
Crossref
Crossref
Tingting Zhou, Xin Xu, Mengfan Du, Tong Zhao & Jiaying Wang. (2018) A preclinical overview of metformin for the treatment of type 2 diabetes. Biomedicine & Pharmacotherapy 106, pages 1227-1235.
Crossref
Crossref
Mahnaz Bahri Khomami, Jacqueline A. Boyle, Chau T. Tay, Eszter Vanky, Helena J. Teede, Anju E. Joham & Lisa J. Moran. (2018) Polycystic ovary syndrome and adverse pregnancy outcomes: Current state of knowledge, challenges and potential implications for practice. Clinical Endocrinology 88:6, pages 761-769.
Crossref
Crossref
Manabu Kato, Hidetoshi Furuie, Emi Kamiyama, Kazuhito Shiosakai, Kazutaka Yoshihara & Takashi Taguchi. (2018) Safety and Pharmacokinetics of DS-8500a, a Novel GPR119 Agonist, After Multiple Oral Doses in Healthy Japanese Males. Clinical Drug Investigation 38:6, pages 519-525.
Crossref
Crossref
Phiwayinkosi V. Dludla, Elizabeth Joubert, Christo J.F. Muller, Johan Louw & Rabia Johnson. (2017) Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-β-D-glucoside. Nutrition & Metabolism 14:1.
Crossref
Crossref
Nagashekhara Molugulu, Lai Shu Yee, Yew Tze Ye, Tan Chew Khee, Lee Zhen Nie, Neoh Jia Yee, Tian Kar Yee, Tan Chee Liang & Prashant Kesharwani. (2017) Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus. Diabetes Research and Clinical Practice 132, pages 157-168.
Crossref
Crossref